• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Alumis Inc. - Common Stock (NQ:ALMS)

    28.25 -0.70 (-2.42%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,321,122
    Open 28.95
    Bid (Size) 24.75 (200)
    Ask (Size) 28.70 (200)
    Prev. Close 28.95
    Today's Range 27.57 - 29.20
    52wk Range 3.760 - 31.35
    Shares Outstanding 53,752,223
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter ↗
    This biotechnology firm develops clinical-stage therapies for autoimmune and neuroinflammatory diseases using proprietary TYK2 inhibitors. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares ↗
    This clinical-stage biotech develops therapies for rare muscle diseases, leveraging its FORCE platform to target significant unmet needs. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +215.5%
    +215.5%
    1 Month
    +6.0%
    +6.0%
    3 Month
    +12.2%
    +12.2%
    6 Month
    +15.3%
    +15.3%
    1 Year
    +582.4%
    +582.4%

    More News

    Read More
    News headline image
    What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing ↗
    Via The Motley Fool
    News headline image
    Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗
    Via The Motley Fool
    News headline image
    Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter. ↗
    Via The Motley Fool
    News headline image
    An Almus (ALMS) Insider Bought 588,000 Shares for $10.0 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    On Thursday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics ETFs Government Stocks
    Unusual volume stocks in Wednesday's session ↗
    Via Chartmill
    Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Stocks
    Dow Clears 49,000 as AI’s “Data Deluge” Ignites a Memory-Stock Melt-Up ↗
    Via Chartmill
    Topics Artificial Intelligence Stocks
    News headline image
    Alumis Stock Hits Record High As Wall Street Cheers Phase 3 Psoriasis ‘Win’ — Analysts See Best-In-Class Potential ↗
    Via Stocktwits
    News headline image
    Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib ↗
    Via The Motley Fool
    Topics Stocks
    News headline image
    The Great Rotation: Small-Caps Lead 2026 Market Charge as Tech Giants Stumble
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    FOCUSfactor® Beverage Emerges as a Growth Catalyst for Synergy CHC Corp. (NASDAQ: SNYR) – Alongside CYCN, ALMS, EVTV, RDZN See Why
    Via AB Newswire
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Tuesday's session. ↗
    Via Chartmill
    News headline image
    Why Is ALMS Stock Rising Today? ↗
    Via Stocktwits
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    Alumis’ Envudeucitinib Delivers Leading Skin Clearance Among Next-Generation Oral Plaque Psoriasis Therapies in Phase 3 Program
    From Alumis Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Alumis Inc. - Common Stock publicly traded?
    Yes, Alumis Inc. - Common Stock is publicly traded.
    What exchange does Alumis Inc. - Common Stock trade on?
    Alumis Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Alumis Inc. - Common Stock?
    The ticker symbol for Alumis Inc. - Common Stock is ALMS on the Nasdaq Stock Market
    What is the current price of Alumis Inc. - Common Stock?
    The current price of Alumis Inc. - Common Stock is 28.25
    When was Alumis Inc. - Common Stock last traded?
    The last trade of Alumis Inc. - Common Stock was at 07/31/26 04:00 PM ET
    What is the market capitalization of Alumis Inc. - Common Stock?
    The market capitalization of Alumis Inc. - Common Stock is 1.52B
    How many shares of Alumis Inc. - Common Stock are outstanding?
    Alumis Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.